DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Capecitabine
Capecitabine
A Phase II Study of Paclitaxel and Capecitabine As a First-Line Combination Chemotherapy for Advanced Gastric Cancer
A Phase II Study of Capecitabine and Docetaxel Combination Chemotherapy in Patients with Advanced Gastric Cancer
Metronomic Chemotherapy
Dosage of Capecitabine and Cyclophosphamide Combination Therapy in Patients with Metastatic Breast Cancer
Capecitabine Induces Rapid, Sustained Response in Two Patients with Extensive Oral Verrucous Carcinoma1
Colorectal Cancer
Predicted Concentrations of Anticancer Drugs in the Aquatic Environment
Dose-Finding Study of Capecitabine in Combination with Weekly Paclitaxel
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Genetic Factors Influencing Pyrimidine- Antagonist Chemotherapy
Capecitabine
Chemotherapeutic Drugs in Lebanese Surface Waters: Estimation of Population Exposure and Identifcation of High-Risk Drugs
The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer
Phase II Study of Oral Capecitabine in Patients with Hormone-Refractory Prostate Cancer
Cancer Drug Costs for a Month of Treatment at Initial Food
Acronyms for Oncology Regimens
The Oral Fluoropyrimidines in Cancer Chemotherapy
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Top View
XELODA (Capecitabine)
Esophageal and Esophagogastric Junction
Oral Chemotherapy Capecitabine (Xeloda®)
In Patients with Metastatic Breast Cancer
Modifying Chemotherapy for the Older Patient
Clinical Study Report
Xeloda, INN-Capecitabine
Chapter 12: Pharmacokinetics of Chemotherapeutic Agents in Kidney Disease
A Phase I and Pharmacokinetic Study of the Combination of Capecitabine
Preliminary Results of Tranilast Treatment for Patients with Advanced Castration-Resistant Prostate Cancer
LCA Oral SACT Counselling Handbook
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
GICART Protocol.Pdf
HOPA News Volume 10, Issue 1
Capecitabine-Induced Hand-Foot Syndrome Complicated by Pseudomonal Superinfection Resulting in Bacterial Sepsis and Death Case Report and Review of the Literature
Capecitabine in Hormone-Resistant Metastatic Prostatic Carcinoma – a Phase II Trial
Emetogenic Potential of Antineoplastic Agents
Randomized Trial of Vitamin B6 for Preventing Hand-Foot Syndrome
Arsenic Trioxide Plus Cisplatin/Interferon Α-2B/Doxorubicin/Capecitabine Combination Chemotherapy for Unresectable Hepatocellul
Patient Information XELODA
CAPIRI (XELIRI Or Irinotecan & Capecitabine)
(XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irino
GICIRB Protocol
Oncology Medications Policy (1403)
Capecitabine
North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
Xeloda (Capecitabine) an Overview of Xeloda and Why It Is Authorised in the EU
Acute Mucositis and Gastrointestinal Toxicity Caused by Radiotherapy Or Systemic Anti-Cancer Treatment 2019
GICAPIRI Protocol
A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer
Clinical Trial Details (PDF Generation Date :- Sat, 21 Aug 2021 13
A Report on the Dispensing and Supply of Oral Chemotherapy and Systemic Anticancer Medicines in Primary Care
Guidelines for the Use of Anti-Emetics with Chemotherapy
Efficacy of the Oral Fluorouracil Pro-Drug Capecitabine in Cancer Treatment: a Review
Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products
Northern Cancer Alliance Standards for the Safe Use of Oral Anticancer
Capecitabine and Oral Cyclophosphamide Combination in Taxane/Antrhracycline Resistant Metastatic Breast Cancer
The Antimetabolites
XELODA (Capecitabine) Is a Fluoropyrimidine Carbamate with Antineoplastic Activity
Chemoradiation with Capecitabine and Mitomycin-C for Stage I-III Anal Squamous Cell Carcinoma
The Role of Capecitabine in the Treatment of Colorectal Cancer in the Elderly
The Randomized Clinical Finxx Trial
Palmar-Plantar Erythrodysesthesia (Ppe) Nci Grade and Management | Resources | Contributing Factors | Appendix
Hazardous Drug List
Radiation Recall Phenomenon Associated with Arsenic Trioxide
Serious Hand-And-Foot Syndrome in Black Patients Treated with Capecitabine: Report of 3 Cases and Review of the Literature
Natural Product and Natural Product Derived Drugs in Clinical Trials
Chemotherapeutic Drugs in Lebanese Surface Waters: Estimation of Population Exposure and Identifcation of High-Risk Drugs